Jolanta Airey
Vermogen: - $ op 31-08-2026
Vermogen: - $ op 31-08-2026
Jolanta Airey is currently Chief Medical Officer at Acrux Ltd. since 2026.
Formerly, served as Chief Medical Officer at Cynata Therapeutics Ltd. from 2021 to 2026, Director-Translational Development at CSL Ltd. from 2017 to 2021, and held the position of Head-Clinical Development Physician at CSL Seqirus Inc. Education includes a doctorate from Vilnius University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-06-2025 | 0 ( -.--% ) | - $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ACRUX LIMITED | Hoofd Techniek/Wetenschap/O&O | 24-08-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
| CYNATA THERAPEUTICS LIMITED | Hoofd Techniek/Wetenschap/O&O | 01-01-2026 |
| CSL LIMITED | Corporate Officer/Principal | 01-10-2021 |
Csl Seqirus
Csl Seqirus BiotechnologyHealth Technology Manufactures influenza vaccine products | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
CSL Ltd.
CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Acrux Ltd.
Acrux Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Vilnius University
Vilnius University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cynata Therapeutics Ltd.
Cynata Therapeutics Ltd. BiotechnologyHealth Technology Engages in stem cell research and development services | Health Technology |
Csl Seqirus
Csl Seqirus BiotechnologyHealth Technology Manufactures influenza vaccine products | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau